EPISODE · Apr 8, 2020 · 12 MIN
Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director
from Morgans Under the Microscope · host Morgans Financial Limited
Morgans Research Analyst Iain Wilkie talks with Mark Diamond, Managing Director of Antisense Therapeutics (ASX:ANP). Mark shares a recap on what the company does, and what potential investors can look out for.
NOW PLAYING
Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m